Tekla Capital Management LLC Gilead Sciences, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 1,533,884 shares of GILD stock, worth $142 Million. This represents 4.68% of its overall portfolio holdings.

Number of Shares
1,533,884
Previous 1,559,884 1.67%
Holding current value
$142 Million
Previous $129 Million 8.66%
% of portfolio
4.68%
Previous 4.97%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
SELL
$76.01 - $86.7 $1.98 Million - $2.25 Million
-26,000 Reduced 1.67%
1,533,884 $118 Million
Q1 2023

May 10, 2023
BUY
$77.31 - $88.08 $3.82 Million - $4.36 Million
49,444 Added 3.27%
1,559,884 $129 Million
Q4 2022

Feb 10, 2023
SELL
$62.32 - $89.47 $6.96 Million - $10 Million
-111,725 Reduced 6.89%
1,510,440 $130 Million
Q3 2022

Nov 01, 2022
SELL
$59.54 - $68.01 $1.7 Million - $1.95 Million
-28,600 Reduced 1.73%
1,622,165 $100 Million
Q2 2022

Jul 29, 2022
SELL
$57.72 - $65.01 $2.07 Million - $2.33 Million
-35,800 Reduced 2.12%
1,650,765 $102 Million
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $1.39 Million - $1.58 Million
-21,500 Reduced 1.26%
1,686,565 $122 Million
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $4.96 Million - $5.35 Million
73,280 Added 4.48%
1,708,065 $119 Million
Q2 2021

Aug 13, 2021
SELL
$63.47 - $69.35 $11.5 Million - $12.6 Million
-181,121 Reduced 9.97%
1,634,785 $113 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $24.6 Million - $28.1 Million
410,535 Added 29.21%
1,815,906 $117 Million
Q4 2020

Feb 12, 2021
SELL
$56.65 - $64.55 $13.5 Million - $15.4 Million
-238,312 Reduced 14.5%
1,405,371 $81.9 Million
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $3.89 Million - $4.89 Million
62,657 Added 3.96%
1,643,683 $104 Million
Q2 2020

Aug 13, 2020
SELL
$72.34 - $84.0 $22.2 Million - $25.8 Million
-307,279 Reduced 16.27%
1,581,026 $122 Million
Q1 2020

May 14, 2020
SELL
$62.63 - $80.22 $142,232 - $182,179
-2,271 Reduced 0.12%
1,888,305 $141 Million
Q4 2019

Feb 13, 2020
BUY
$61.62 - $67.78 $3.49 Million - $3.84 Million
56,594 Added 3.09%
1,890,576 $123 Million
Q3 2019

Nov 13, 2019
SELL
$62.51 - $69.0 $133,146 - $146,970
-2,130 Reduced 0.12%
1,833,982 $116 Million
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $5.37 Million - $6.02 Million
86,724 Added 4.96%
1,836,112 $124 Million
Q1 2019

May 14, 2019
SELL
$62.53 - $70.05 $8.78 Million - $9.84 Million
-140,458 Reduced 7.43%
1,749,388 $114 Million
Q4 2018

Feb 13, 2019
SELL
$60.54 - $79.0 $3.18 Million - $4.15 Million
-52,471 Reduced 2.7%
1,889,846 $118 Million
Q3 2018

Nov 13, 2018
SELL
$71.28 - $78.92 $8.65 Million - $9.58 Million
-121,382 Reduced 5.88%
1,942,317 $150 Million
Q1 2018

May 14, 2018
SELL
$72.84 - $88.8 $33.3 Million - $40.5 Million
-456,582 Reduced 18.12%
2,063,699 $156 Million
Q4 2017

Feb 14, 2018
SELL
$71.15 - $83.52 $20 Million - $23.5 Million
-280,850 Reduced 10.03%
2,520,281 $181 Million
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $19.5 Million - $23.2 Million
271,000 Added 10.71%
2,801,131 $227 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,530,131
2,530,131 $179 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email